(Q77811615)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

N P Mendenhall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L L Rodrigue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G J Moore-Higgs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R B Marcus

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R R Million

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

551-561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Thyroid Diseases after Treatment of Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Patterns of care outcome studies. Results of the national practice in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Daily reproducibility of lung blocks in the mantle technique

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Pericarditis and myocardial infarctions after Hodgkin's disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Cardiac disease following treatment of Hodgkin's disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Hodgkin's disease, stages I and II.Relationship of recurrence to size of disease, radiation dose, and number of sites involved

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Definitive irradiation in the treatment of Hodgkin's disease. Analysis of outcome, prognostic factors, and long-term complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

An updated dose-response analysis in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

A re-analysis of available dose-response and time-dose data in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

Tumor burden as the most important prognostic factor in early stage Hodgkin's disease.Relations to other prognostic factors and implications for choice of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900087-5

7 January 2021

10.1016/S0360-3016(99)00087-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348284%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference